These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 21601454

  • 1. Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists.
    Baker J, Bingham M, Blackburn-Munro R, Cai J, Craighead M, Gilfillan R, Goan K, Jaap D, Milne R, Morphy JR, Napier S, Presland J, Spinks G, Thomson F.
    Bioorg Med Chem Lett; 2011 Jun 15; 21(12):3603-7. PubMed ID: 21601454
    [Abstract] [Full Text] [Related]

  • 2. Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.
    Scott JD, Miller MW, Li SW, Lin SI, Vaccaro HA, Hong L, Mullins DE, Guzzi M, Weinstein J, Hodgson RA, Varty GB, Stamford AW, Chan TY, McKittrick BA, Greenlee WJ, Priestley T, Parker EM.
    Bioorg Med Chem Lett; 2009 Nov 01; 19(21):6018-22. PubMed ID: 19800231
    [Abstract] [Full Text] [Related]

  • 3. Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists.
    Letourneau JJ, Riviello CM, Li H, Cole AG, Ho KK, Zanetakos HA, Desai H, Zhao J, Auld DS, Napier SE, Thomson FJ, Goan KA, Morphy JR, Ohlmeyer MH, Webb ML.
    Bioorg Med Chem Lett; 2010 Sep 15; 20(18):5394-7. PubMed ID: 20719508
    [Abstract] [Full Text] [Related]

  • 4. The characterization of a novel V1b antagonist lead series.
    Smethurst CA, Borthwick JA, Gaines S, Watson S, Green A, Schulz MJ, Burton G, Buson AA, Arban R.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):92-6. PubMed ID: 21146408
    [Abstract] [Full Text] [Related]

  • 5. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
    Procopiou PA, Ford AJ, Graves RH, Hall DA, Hodgson ST, Lacroix YM, Needham D, Slack RJ.
    Bioorg Med Chem Lett; 2012 Apr 15; 22(8):2730-3. PubMed ID: 22437117
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.
    Napier SE, Letourneau JJ, Ansari N, Auld DS, Baker J, Best S, Campbell-Wan L, Chan JH, Craighead M, Desai H, Goan KA, Ho KK, Hulskotte EG, MacSweeney CP, Milne R, Morphy JR, Neagu I, Ohlmeyer MH, Peeters AW, Presland J, Riviello C, Ruigt GS, Thomson FJ, Zanetakos HA, Zhao J, Webb ML.
    Bioorg Med Chem Lett; 2011 Mar 15; 21(6):1871-5. PubMed ID: 21353540
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.
    Napier SE, Letourneau JJ, Ansari N, Auld DS, Baker J, Best S, Campbell-Wan L, Chan R, Craighead M, Desai H, Ho KK, MacSweeney C, Milne R, Richard Morphy J, Neagu I, Ohlmeyer MH, Pick J, Presland J, Riviello C, Zanetakos HA, Zhao J, Webb ML.
    Bioorg Med Chem Lett; 2011 Jun 15; 21(12):3813-7. PubMed ID: 21596563
    [Abstract] [Full Text] [Related]

  • 8. Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
    Quattropani A, Dorbais J, Covini D, Pittet PA, Colovray V, Thomas RJ, Coxhead R, Halazy S, Scheer A, Missotten M, Ayala G, Bradshaw C, De Raemy-Schenk AM, Nichols A, Cirillo R, Tos EG, Giachetti C, Golzio L, Marinelli P, Church DJ, Barberis C, Chollet A, Schwarz MK.
    J Med Chem; 2005 Dec 01; 48(24):7882-905. PubMed ID: 16302826
    [Abstract] [Full Text] [Related]

  • 9. Discovery and optimisation of a potent and selective tertiary sulfonamide oxytocin antagonist.
    Barton NP, Bellenie BR, Doran AT, Emmons AJ, Heer JP, Salvagno CM.
    Bioorg Med Chem Lett; 2009 Jan 15; 19(2):528-32. PubMed ID: 19081251
    [Abstract] [Full Text] [Related]

  • 10. Small-molecule vasopressin-2 receptor antagonist identified by a g-protein coupled receptor "pathway" screen.
    Yangthara B, Mills A, Chatsudthipong V, Tradtrantip L, Verkman AS.
    Mol Pharmacol; 2007 Jul 15; 72(1):86-94. PubMed ID: 17435162
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists.
    Futatsugi K, Piotrowski DW, Casimiro-Garcia A, Robinson S, Sammons M, Loria PM, Banker ME, Petersen DN, Schmidt NJ.
    Bioorg Med Chem Lett; 2013 Dec 01; 23(23):6239-42. PubMed ID: 24157365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations.
    Guillon G, Derick S, Pena A, Cheng LL, Stoev S, Seyer R, Morgat JL, Barberis C, Gal CS, Wagnon J, Manning M.
    J Neuroendocrinol; 2004 Apr 01; 16(4):356-61. PubMed ID: 15089974
    [Abstract] [Full Text] [Related]

  • 14. Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.
    Wang Y, Busch-Petersen J, Wang F, Kiesow TJ, Graybill TL, Jin J, Yang Z, Foley JJ, Hunsberger GE, Schmidt DB, Sarau HM, Capper-Spudich EA, Wu Z, Fisher LS, McQueney MS, Rivero RA, Widdowson KL.
    Bioorg Med Chem Lett; 2009 Jan 01; 19(1):114-8. PubMed ID: 19014886
    [Abstract] [Full Text] [Related]

  • 15. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G.
    J Med Chem; 2004 Apr 22; 47(9):2375-88. PubMed ID: 15084136
    [Abstract] [Full Text] [Related]

  • 16. Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: novel, potent, and selective series of Vasopressin 1b receptor antagonists.
    Arban R, Bianchi F, Buson A, Cremonesi S, Di Fabio R, Gentile G, Micheli F, Pasquarello A, Pozzan A, Tarsi L, Terreni S, Tonelli F.
    Bioorg Med Chem Lett; 2010 Sep 01; 20(17):5044-9. PubMed ID: 20674355
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.